Design of a Phase I Clinical Trial to evaluate intra-tumoral delivery of ErbB-targeted CAR T-cells in locally advanced or recurrent Head and Neck Cancer
2013; Mary Ann Liebert, Inc.; Linguagem: Inglês
10.1089/hum.2013.144
ISSN2324-8645
AutoresMay C I van Schalkwyk, Sophie Papa, Jean‐Pierre Jeannon, Teresa Guerrero Urbano, James Spicer, John Maher,
Tópico(s)Immunotherapy and Immune Responses
Referência(s)